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Abstract 
Pain experienced by many patients with advanced cancer is often not well controlled and 
community pharmacists are potentially well placed to provide support. The study objective was 
to explore the views and experiences of patients with advanced cancer about community 
pharmacies, their services and attitudes towards having a community pharmacist pain 
medicines consultation.  
Purposive sampling of GP clinical information systems was used to recruit patients with 
advanced cancer, living in the community and receiving opioid analgesics in one area of 
England, UK between January 2015 and July 2016. Thirteen patients had a semi-structured 
interview which was audio-recorded and transcribed verbatim.  Data were analysed deductively 
and inductively using Framework Analysis and incorporating new themes as they emerged. The 
framework comprised Pain management, Experiences and expectations, Access to care and 
Communication.  
All patients reported using one regular community pharmacy citing convenience, service and 
staff friendliness as influential factors. The idea of a community pharmacy medicines 
consultation was acceptable to most patients. The idea of telephone consultations was 
positively received but electronic media such as Skype was not feasible or acceptable for most. 
Patients perceived a hierarchy of health professionals with specialist palliative care nurses at the 
top (due to their combined knowledge of their condition and medicines) followed by GPs then 
pharmacists. Patients receiving specialist palliative care described pain that was better 
controlled than those who were not. They thought medicines consultations with a pharmacist 
could be useful for patients before referral for palliative care.  
There is a need for pain medicines support for patients with advanced cancer, unmet need 
appears greater for those not under the care of specialist services. Medicines consultations, in 
principle, are acceptable to patients both in-person and by telephone, the latter was perceived 
to be of particular benefit to patients less able to leave the house. 
Keywords: cancer, pharmacy practice research, palliative care, needs and experiences of cancer 
patients, community pharmacy, medicines. 
What is known about this topic 
 Pain in advanced cancer is often complex, rapidly changing and poorly controlled. 
 Patients with cancer pain rarely access community pharmacy medicines consultation 
services. 
What this paper adds 
 Patients without access to specialist palliative care services appear to need more 
support with their pain medicines. 
 Patients are open to the idea of medicines consultations with their community 
pharmacist in person or by telephone. 
 There is concern that the addition of community pharmacists into the palliative care 
pathway could cause conflict between or duplication of services. 
 
Introduction 
Three quarters of people who die from cancer will have experienced pain and it is the most 
common reason patients with cancer contact out-of-hours services (IMPACCT 2016, Adam 
2015). Pain is less well controlled among patients living in community settings compared with 
those in the hospice or hospital (VOICES 2014). Cancer pain is complex and often changes 
rapidly with disease progression (Hackett 2016). Many patients increasingly want to spend their 
last days and weeks in their own homes which has created an increasing need for community-
based patients to be better supported to ensure they receive pain management (Closs 2009, 
Bennett 2009a, Adam 2015). Community pharmacies are situated in every locality and are often 
open up to 100 hours a week giving patients free and easy access to a healthcare professional 
without the need to wait for an appointment however they are widely thought to be an 
underused resource as many patients often don’t realise they can be a source of medicines 
information (Bennie 2013). 
In the British National Health Service (NHS) community pharmacists are funded to provide 
patient-centred medicines optimisation services that could support patients with less well-
controlled cancer pain. However the sparse research in this area found that these services are 
rarely carried out with this patient group (Savage 2013).  Medicine optimisation services 
currently available in community pharmacies in England and Wales include the Medicines Use 
Review (MUR) and the New Medicine Service (NMS). MURs are consultations with patients 
where all patient medication is discussed and explained and often issues around concordance, 
compliance and supply are addressed. NMS concentrates on newly prescribed medicines and 
involves two consultations (usually by telephone) to ensure medicines are started and no side 
effects or problems ensue.  There is RCT evidence that NMS detects adverse effects from 
medicines, positively influences prescribing and improves treatment adherence (NMS 
Evaluation 2014). A recent review of the limited evidence relating to MUR concluded that “in 
line with their intended purpose, patient knowledge and self-reported adherence may improve 
following MURs” (Wright 2016 p37). 
Current policy allows community pharmacists to carry out MURs with patients living with cancer 
pain, but the NMS service can only be provided for patients being newly prescribed medicines 
for certain conditions; cancer and pain are not included (PSNC 2017). MURs are intended to be 
provided face-to-face when a patient is in the pharmacy unless permission is requested on an 
individual patient basis from NHS England (PSNC 2017). Patients with advanced cancer may not 
come into pharmacies and their medicines are often collected by relatives or supplied by 
delivery drivers (Savage 2013).  
Where medicines optimisation interventions have been carried out with patients suffering from 
cancer pain there is evidence of benefit; systematic reviews of educational interventions for 
cancer pain (by any healthcare professional) found a reduction in average and worst pain 
intensity. Pharmacist educational interventions for patients with chronic pain showed a 
reduction in pain intensity, adverse events and an improvement in satisfaction with treatment 
(Bennett 2009a, Bennett 2011). There are no systematic reviews of pharmacist interventions for 
cancer pain as very few studies have ever been carried out and no RCTs. 
Community pharmacists are the health professional with whom patients with cancer pain have 
most frequent contact alongside palliative care nurses with 75% of patients having contact 
within a 2 week period (Bennett 2009b).  
Community pharmacists can currently access only limited information about their patients  and 
they do not routinely know which of their patients have cancer. A previous study with 
community pharmacists found that little communication occurs between them and other 
healthcare professionals about the care of patients with cancer with pharmacists rarely finding 
out the diagnosis of the patients whose medicines they were dispensing (Savage  2013). The 
introduction of Summary Care Record (SCR) access for community pharmacies in 2016 has 
improved information sharing but not all prescribing is recorded and diagnoses are rarely 
included. 
Research on community pharmacists’ views about providing services for patients with cancer 
indicates a perceived lack of knowledge and need for training (Savage 2013, O’Connor 2013). 
However little research has investigated how patients with advanced cancer use community 
pharmacies and attitudes towards having medicines consultations. 
Aims 
 To explore the views and experiences of patients with advanced cancer about 
community pharmacy and its services and the associated challenges they may face. 
 To investigate the acceptability of community pharmacy medicines consultation services 
and find out what patients with cancer pain might need from such a service. 
 
Method 
A qualitative method of semi-structured interviews was chosen as the study topic was complex 
and so far unexplored (Bowling 1997). Following a review of the literature the interview 
schedule was developed in-line with the study aims. Topics included current interaction with 
pharmacy, services and experiences of them and views on potential future services (see 
Supporting Material: Table 1). Interviews were semi-structured in design to ensure focus on the 
research aims whilst allowing in-depth discussion on points of interest. The interview was 
piloted with two patients and minor amendments to language were made.  
This research is part of the wider IMPACCT (Improving the management of pain from advanced 
cancer in the community) programme which is a multi-disciplinary body of work involving Leeds, 
Bradford and York Universities. Ethical permission was granted from Leeds West Ethics 
committee. 
Sampling and recruitment 
Purposive sampling was carried out to ensure focus on the views of patients experiencing pain 
from advanced cancer. The assumption was made that patients would have some 
involvement/contact with community pharmacies through dispensing of prescribed medicines. 
 
The inclusion criteria for patients were:  
• Aged over 16 years 
• Have advanced cancer*, are aware of their diagnosis and are experiencing pain 
• Have been prescribed a strong or moderate opioid for cancer pain within the last three 
months** 
• Have not been prescribed anticipatory medicines and are not considered to be in the 
last days of life 
• Have capacity to provide informed consent 
• Have capacity to complete questionnaires before and after the medicines consultation. 
*People with advanced cancer are those with metastatic cancer with histological, cytological or 
radial evidence and/or those receiving anti-cancer therapy with palliative intent. 
**Strong and moderate opioids are codeine, codeine and paracetamol, codeine and ibuprofen, 
dihydrocodeine, paracetamol and hydrocodeine, tramadol, tapentadol, morphine, fentanyl, 
buprenorphine, diamorphine, hydromorphone, methadone and oxycodone. 
 
Patients were recruited from GP practices in one area of England between January 2015 and 
July 2016 to take part in an interview with a researcher. Research-ready practices which 
employed a practice pharmacist were selected from areas of differing deprivation scores within 
the area to represent the wider population (Open Data Communities 2015). The researcher was 
not allowed direct access to the practice clinical information system so practice pharmacists 
carried out searches. Letters of invitation were sent to the practice manager, with telephone 
follow up by ZE and meetings were arranged to discuss the research where the practice wished 
to do so. 21 surgeries were invited to take part and 16 agreed to do so.  
Each practice pharmacist carried out a pre-designed search of the practice clinical information 
system to identify patients who had any cancer code attached to their record. The practice 
pharmacist then individually searched the patients’ record to check whether their cancer code 
was current and they had advanced cancer. 
For those patients identified as being potentially eligible to take part, a task was sent to their GP 
to ask whether they were suitable for inclusion in the study i.e. they had capacity to provide 
informed consent and had not deteriorated since the search. A letter of invitation, participation 
information sheet and consent form were then posted from the surgery including details of the 
research pharmacist, why the research was being carried out and what would happen. 
Completed consent forms were returned to the research pharmacist at the university. 
Reminders were not sent as the health of this patient group is likely to change rapidly leading to 
changes in eligibility. 
The target sample size was 15 patients or when data saturation was reached (Malterud 2016 , 
Fusch 2015). 
Data collection 
The interview guide was developed using the aims of the study and is available as a supplement 
to this paper (Supporting material: Table1). Participants were given the choice as to where they 
would like the interview to be carried out and were asked if they would like to have a family 
member or carer present with them during the interview. The research pharmacist carried out 
the majority of interviews with a second researcher helping when the research pharmacist was 
unavailable. Although the research pharmacist had limited experience of interviewing, they had 
extensive consultation experience and were supported by a highly experienced research lead 
and wider group. Following each interview the researcher carrying out the interview wrote 
reflective field notes to support analysis. Patients were recruited and interviewed until two 
interviews after no new themes emerged, at which point it was concluded that data saturation 
had occurred (Fusch 2015). 
Data analysis 
Interviews were audio recorded and transcribed verbatim before being analysed using thematic 
Framework analysis by the research pharmacist (Ritchie and Lewis 2003). This method was 
chosen as it allows analysis across participants leading to the development of meaningful 
themes whilst still allowing the context of each individual taking part (Gale 2013, Smith 2011). A 
combined approach of inductive and deductive analysis was used. We were interested in 
pharmacy use in patients with cancer pain however we wanted the qualitative interview data to 
inform our themes and allow unexpected findings to be explored (Gale 2013). 
Interview transcripts were read and re-read by ZE and AB to gain familiarity alongside field 
notes from both researchers (ZE and MA) following which a framework was developed. The 
framework was then applied to the data. Data was then sorted into similar concepts before 
being summarised. Descriptive categories were then allocated and refined by ZE, AB and BF 
several times until the authors were satisfied with the themes and sub-themes assigned. 
In the Results section which follows the verbatim quotations from participants are coded using a 
site-code (S) and a patient number code (P). C corresponds to a carer or family member who 
was involved in the interview. 
 
 
 
Findings 
In total 121 patients were identified from searches of GP clinical information systems and 
subsequent individual review of notes. GP’s assessed seventy-three patients were suitable for 
invitation and were sent an invitation pack. 
Thirteen patients returned a completed consent form and agreed to be interviewed (from 7 of 
the 16 surgeries) and all requested the interview to take place in their own home. Patients were 
aged between 40 and 89 years old; 10 were male and 3 were female and they lived in areas with 
deprivation scores of between 2 and 10 (Open Data Communities 2015). Interviews lasted 
between 27 and 51 minutes and none were repeated. Saturation of themes was apparent after 
the eleventh interview.  Table 1 summarises key characteristics of the patients in the study.  
Three patients were interviewed in the presence of family members who also contributed to the 
discussion. 
Table 1: Patient characteristics 
Patient Gender Age 
years 
Depriv-
ation 
score of 
postcode* 
Employment 
status 
Social 
circums-
tances 
Comm-
unity 
Pharmacy 
Use 
Under 
specialist 
palliative 
care 
services 
Awareness or 
experience of 
community 
pharmacy 
medicines 
consultation 
services 
S1P1*
** 
F 89 6 Retired Lives 
alone 
Regular No No 
S1P2*
** 
M 68 6 Retired Lives 
with 
partner 
Regular No Yes 
S1P3 M 81 6 Retired Lives Regular No Yes 
with 
partner 
S2P1 M 61 2 Employed Off 
sick 
Lives 
alone 
Regular No No 
S5P1 M 68 10 Employed Lives 
alone 
Regular Yes Yes 
S5P2 M 70 10 Retired Lives 
with 
partner 
Regular Yes No 
S5P3 M 82 10 Retired Family 
staying 
Regular Yes Yes 
S5P4 M 52 10 Employed Off 
sick 
Lives 
with 
family 
Regular Yes No 
S7P1 M 50 4 Unemployed Lives 
alone 
Regular No Yes 
S8P1 M 58 10 Retired Lives 
with 
partner 
Regular Yes** Yes 
S10P1 M 77 6 Retired Lives 
with 
partner 
Regular Yes Yes 
S13P1 F 55 6 Employed Lives 
with 
family 
Regular No No 
S13P2 F 40 6 Employed Off 
sick 
Lives 
with 
family 
Regular Yes No 
*Deprivation scores where 1 is the most deprived centile and 10 is the least (Open Data 
Communities 2015). 
** In regular contact with Hospital ward nurses. 
***Interviews carried out by MA. All other carried out by ZE. 
Interview findings 
Ten sub-themes were identified from the analysis (between two and three per theme) (Fig. 1) 
Figure 1: Summary of themes and subthemes found in qualitative interviews with patients 
suffering from advanced cancer exploring use of pharmacy and its services. 
 
Pain management 
Adequacy of pain control 
Pain levels and reported adequacy of pain control varied considerably among the patients. 
Those receiving specialist palliative care appeared to be more comfortable with how to manage 
their pain and who to turn to for help. They explained how their medication could be changed in 
a timely manner in response to changing needs. 
The patients who were not receiving specialist palliative care services seemed to have pain that 
was less well controlled. 
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Knowledge of medicines 
Some patients were very knowledgeable about their pain medicines while others appeared to 
know little and voiced a need for more information that could give them practical advice on 
how to get the best from their medicines. 
Some patients did not realise that they had insufficient knowledge to be able to use their 
medicines to manage their pain and were unsure of which medicine was being used for which 
symptom. One patient did not know what their MST (morphine sulphate prolonged release) 
tablets were for. It seems unlikely that this patient would be able to adequately control their 
fluctuating pain levels with regular and top-up medication without a better understanding of 
their purpose.  
Experimentation with medicines 
Experimentation through reducing the dosage taken was sometimes in response to concerns 
over addiction and tolerance (where a patient believed that the medicine might become less 
effective if taken over a period of time). Some patients were uncomfortable with their ‘tablet 
burden’ and wanted to reduce medicine taking to the lowest possible level that would still 
control symptoms. 
Occasionally professionals were reported to have been dismissive of patients’ fears and 
anxieties, leading to patients not seeking further advice from them. One patient had tried to 
voice their concerns about taking too much pain medication to their healthcare professional 
and went on to reduce their medicine taking on their own.  
 
 
 
Box 1: Pain management 
Adequacy of control 
“…if the pain gets more severe, I’ll ring [the Macmillan nurse] up and say I can’t go on like this! 
[The nurse says] ok, we’ll talk to the doctor, increase the dosage of the patch.”  S10P1 
 
“Every day up to a point… there’s something, some pain somewhere…they’ve referred me 
somewhere. Don’t know where.”  S7P1 
 
Knowledge of medicines 
“I just wish sometimes that there’d be a little sheet really almost that sort of said you know do 
this, do that”  S13P1 
 
“So you take MST as well?” Interviewer 
  “That’s it yeah…Is that a painkiller?” S1P1 
 
Experimentation 
“I’m always experimenting actually…I don’t know if that’s a good thing or not.”  S13P1 
 
[The doctor said] “we can see that…there isn’t a right lot we can do about it, you know you just 
have to [take them].  S8P1 
 
 
 
 
Experiences and Expectations 
Community Pharmacies 
All patients interviewed reported using one regular community pharmacy (one, also additionally 
used a hospital pharmacy regularly at outpatient visits for specially prescribed treatment). 
Pharmacy location was important, sometimes through convenience and the pharmacy’s 
proximity to the patient’s GP surgery. Some patients talked about a preference for independent 
pharmacies rather than chains. 
One patient had limited mobility and spoke about having to leave plenty of time to walk to the 
bus stop before catching the bus to the GP surgery. Using the pharmacy next to the surgery 
made their life much easier. 
Service was also an important factor for patients in choosing which community pharmacy to use 
and several patients had changed pharmacies after repeated perceptions of poor service.  
In contrast some patients described having ‘good relationships’ with their community pharmacy 
team. Examples of how these relationships manifested themselves were where pharmacy staff 
knew the patient’s name or were reported to have gone “above and beyond” what might be 
expected from them. 
Patients felt that occasional problems with pharmacies such as mistakes or stock issues could 
sometimes be forgiven if they perceived the staff to be friendly and trying their best. 
The positive experiences were not without exception and lack of relationship rather than a 
negative relationship was expressed. 
Patients seemed to value more than just the basic level of service from their community 
pharmacy and wanted to be treated with friendliness by staff who knew them. This attribute 
positively influences the continuity of pharmacy use. 
Hierarchy of professionals 
Patients perceived a hierarchy of professionals with whom they came into contact in primary 
care depending on who was involved and the stage in their cancer journey they were at (e.g. 
diagnosis, treatment, non-treatment and palliative care). Those patients who were under the 
care of specialist palliative care services would, without exception, always refer any problem to 
them.  
One patient believed the specialist palliative care nurse had more expertise about cancer than 
GPs as well as dealing with cancer pain on a day-to-day basis 
The GP was viewed as second in line to go to for advice, or first in line if the patient did not have 
access to palliative care advice. 
The community pharmacist was mentioned by one patient as being an option for advice.  
One patient who reported positive experience of clinical interventions questioned the capability 
of community pharmacists to provide advice as they may have less knowledge about medicines 
than doctors. 
 
Support for medicines taking 
Patients were introduced to the idea of a community pharmacy medicines consultation to 
support medicines taking. Although seven patients were aware of community pharmacy 
services, only three had experience of them and none of these had been since their cancer 
diagnosis 
The need for support was felt more by those were not receiving palliative care services and 
therefore did not have direct access to advice from palliative care professionals.  
Patients were positive about the prospect of receiving community pharmacy services to help 
with their medicines use but many saw that as being the role of their GP. 
The patients described how their medicines and doses had changed over time, making support 
after a medicine is prescribed - important and useful. 
Box 2: Expectations and experiences 
Community pharmacies 
“It’s our local pharmacy because it’s the nearest….and it’s right next to the GP. So if the GP gives 
you a prescription . . . . .  you just pop into the pharmacy next door. Its…the whole experience of 
supporting your local community…rather than a big chain.”  S5P4 
 
“[The pharmacy] is directly opposite the doctors it’s the easiest one…I get my prescription then I 
can just walk over and get it there.” S7P1 
 
“[the other pharmacy] didn’t seem to like over stocking so it was always having to go back for 
the owing note… it was also the unfriendliness of the staff” S5P2 
 
“They’re lovely… I erm got there to pick my medication up and one of the pharmacists, he says 
are you alright? I says no I’m not so I told him what my problem was. He says have you a minute 
so I can talk about it and he sat down with me…they really are very nice.  S1P3C 
 
“But they’re smashing and I mean sometimes they do leave stuff off or forget stuff or 
whatever…but I mean they are really, really good I mean I’ve never had any bother with them”  
S8P1 
 
“They’re not rude but at the same time they’re not overly friendly”  S13P2 
 
Hierarchy 
“I don’t see the doctor…I deal with the Macmillan Nurse….[they] visit me regularly erm I’ve no 
doubt I’ll be seeing [them] next week, [they] just phone up and ask if it’s ok to come along er, I 
just can’t fault [them].”  S5P2 
 
“Before you were in touch with [the palliative care nurse], was there anyone else you’d speak 
to? “ Interviewer 
“Straight to the doctor” (640) S10P1 
 
“If I couldn’t get into the doctor I’d ring the pharmacy”  S1P3 
 
“Because they can be very helpful can the pharmacists but they might not, I mean they aren’t 
qualified doctors so they might just give you something thinking they were very helpful and you 
might take it and it might upset the cart…”  S1P1 
 
Support for medicines taking 
“If I were offered [a community pharmacy consultation] then I wouldn’t take it up because I 
prefer to speak to my doctor… who knows more about me than anyone else”  S5P3 
 
“Well [they] can’t tell me about that, it’s got to be my cancer specialist (nurse)” S2P1. 
 
“I was thinking that this week, thinking I’d really like to just talk to someone and say is it OK to 
just do this and take that every day once a day without taking Lansoprazole or is that going to 
really affect my stomach, you know it’s like I don’t know the answer to that so there’s lots of 
questions around it.” S13P1 
 
“I’m just still in a lot of pain”  S7P1 
 “What do you do when that happens? Who do you talk to?” Interviewer 
 “Erm, I just sort of struggle through” S7P1 
 
“I think that’s a good idea…and it would be good to review that occasionally. But I thought that 
would be done by the doctor who is, is treating you.” S5P4 
“It’s quite a good idea … especially with the cancer medication and they do have a lot of side 
effects and sometimes even if they discuss the side effects… when you’re experiencing the side 
effects, you do wonder [should it really be] as bad as this?”  S13P2  
 
 
 
Access to care 
Resilience and responsibility 
Patients talked about problems they experienced with managing supplies of their medicines and 
strategies they used either at the time or developed following an incident to prevent it 
happening again. 
Early ordering of prescriptions to allow the pharmacy time to order items not in stock was a 
common way to prevent a patient from running out of medicines.  
When a patient was seen by a doctor outside of usual working hours this posed particular 
challenges. One patient explained about a time they had been given a prescription for 
emergency painkillers at 2am and there was no community pharmacy open where it could be 
dispensed. 
The prescribing doctor was not able to suggest a solution, and it was only afterwards that the 
patient thought of a different way that they might have been able to get the medicine. 
 
Alternative methods to access/contact healthcare professionals 
Patients were familiar with contacting healthcare professionals by telephone and many 
described ordering medication by phone or ringing community pharmacies with queries. Most 
patients would accept medicines consultations with their pharmacist by telephone, and some 
thought that this method would be easier due to mobility problems or trying to fit in multiple 
health appointments around other commitments. 
Some patients preferred face-to-face contact with a healthcare professional and one raised 
potential communication difficulties which may occur with telephone conversations. 
Patients were also asked how they felt about the possibility of using electronic devices 
(computers, smartphones etc) to access healthcare professionals using tools such as Skype or 
Facetime. Four patients responded positively however, most of the patients voiced their lack of 
access to computers or computer literacy as reasons for not wanting access in this form.  
Box 3: Access to care 
Resilience and responsibility 
“If I was very late with any prescription it was usually [the pharmacy’s] delivery that was [the 
problem]. It wasn’t [the pharmacist’s] fault, do you know what I mean. Yeah so I worked it so I 
was ordering like a week to two weeks before I actually needed it”  S5P1 
 “The pain was so bad, excruciating and at that time we couldn’t get hold of any medication. 
Went to [two neighbouring towns]. (The prescriber) said [they, they didn’t] think there are any 
pharmacies open……I think you know in hindsight I think I should have just gone to A & E 
because that’s so bad, because you know the pain was so bad I think, nobody believed me that 
it was so bad.”  S13P2 
 
Alternative methods to access/contact healthcare professionals 
Talking about a community pharmacy consultation “But then what I’m thinking is then it’s 
another drive, it’s another appointment, it’s another appointment to deal with is what I’m 
thinking.”  S13P1 
“What about if it was done by telephone?”  Interviewer 
“Yeah, that would be alright…I really wouldn’t want to have to drive to another appointment. 
You know it’s bad enough fitting everything in as it is really around working and living.”  S13P1 
 
“I would very much prefer face-to-face contact….Em over the phone is possible as well but the 
medication... is, it’s, it’s.. they all have these fancy names and you need to have to, you can’t 
remember it!... But em…you need to be very organised and have a list and have it all written 
down and pronounce them all correctly and stuff”  S5P4 
 
“I haven’t got a computer and I don’t want one.”  S1P1 
“We’re not that technical….we’d rather just go and talk to somebody.”  S1P2 
 
 
 
Table 2: Patients’ ownership of technology and acceptability of different methods of service 
provision 
Patient Use of computer Acceptability of telephone 
consultation 
Acceptability of Skype 
consultation 
S1P1 Not owned Acceptable No access 
S1P2 Owned Prefers face-to face Lacks technical ability 
S1P3 Owned Acceptable Lacks technical ability 
S2P1 Owned                                                                               Acceptable Not acceptable 
S5P1 Owned Acceptable Not acceptable 
S5P2 Owned Acceptable Not acceptable 
S5P3 Not disclosed Not acceptable Not acceptable 
S5P4 Owned Prefers face-to-face Acceptable 
S7P1 Not disclosed Acceptable Not disclosed 
S8P1 Owned Acceptable Acceptable 
S10P1 Owned Acceptable Acceptable 
S13P1 Owned Acceptable Acceptable 
S13P2 Owned Acceptable Not acceptable 
 
Communication 
Conflict and Duplication 
The patients in this study were receiving care from many healthcare professionals and described 
how they sometimes received conflicting messages. 
Where a patient thought they had access to sufficient advice about pain medicines the 
involvement of an extra person such as the community pharmacist was seen as having potential 
to introduce further conflicting advice. 
Patient-centred communication 
When talking about communication between healthcare professionals, one patient was 
surprised to learn their community pharmacist did not have access to their records as their 
perception was that they were a ‘safety-net’ where all their medicines from different sources 
were collated and checked. There was an assumption that communication between the 
different professionals and across care transitions occurred more than it did in reality. 
Box 4: Communication 
Conflict and Duplication 
“….trying one thing after another and it isn’t working, they’ve been doing it for years and it isn’t 
working and being told that there isn’t an operation they can do to cure it but my GP says there 
is”  S1P2 
 
“I don’t like conflicts….. I don’t want different people telling me different things… I’m really 
happy with the Macmillan nurse – I don’t want somebody saying [they are] wrong” S5P2 
 
Patient-centred communication 
“The hospitals usually send a letter to your GP don’t they? I don’t suppose they do that with the 
pharmacy…ask for it or whatever to be sort of emailed over to them”  S7P1 
“So if you have been prescribed something in hospital and pick it up from [the] pharmacy, (the 
community pharmacy) wouldn’t even know about it? That’s not good! …But there might be 
some, some erm…interference or interaction between this new medication and the long list of 
stuff that you’re already [taking]”  S5P4 
  
Discussion 
This study explored patients’ perspectives about community pharmacy services in the context of 
pain management in advanced cancer. Our findings confirm those of other studies that there is 
unmet need for additional medicines support for some patients (and their carers) during pain 
management in palliative care in cancer (Closs 2009, Latter 2016, Bennett 2009a, Adam 2015).  
Similar numbers of patients in this study were receiving and not receiving specialist palliative 
care services therefore allowing insight into the needs, experiences and perceptions of both 
groups.   
To our knowledge this study is the first to explore continuity of pharmacy use and the only to 
explore use by patients with advanced cancer. Patients’ views of their community pharmacies 
varied and most used them only for medicines supplies and occasional advice. Few were aware 
of medicines consultation services and even fewer had used them. This finding supported 
previous research which found that pharmacists reported rarely carrying out medicines 
consultations with this patient group (Savage 2013). Patients provided little evidence of a 
‘clinical’ relationship with their community pharmacist. Instead patients spoke mainly about 
what they perceived as ‘good’ service and many had changed pharmacies in the past to obtain 
the service they wanted occasionally accepting a trade-off where friendly staff were perceived 
to compensate for inadequacies in reliability and accuracy of medicines supply. Interestingly, all 
participants had a regular community pharmacy and the choice of this was based on service, 
location and for some whether it was an independent business or not. 
Whilst most patients regarded their pharmacist in a positive light and some quoted occasions 
where the pharmacist made clinical contributions to their care, the pharmacist’s knowledge 
about cancer pain and their place in the preferred order of who to contact was low. Patients 
perceived the need for not only medicines knowledge but also specialised clinical knowledge 
about their specific cancer and access to their medical history.  The ideal support seemed to be 
in the form of a specialist palliative care nurse who had a combination of knowledge and 
expertise relating to both medicines and cancer along with access to their medical history. 
General practitioners were next followed by the community pharmacist. This is in line with 
findings from a previous knowledge-based study where nurses were found to know the most, 
followed by GPs and pharmacists with regards to pain assessment in palliative care (Furstenburg 
1998). Several other studies have also demonstrated a need for further pharmacist training in 
palliative care knowledge and issues surrounding difficult conversations (Savage 2013, O’Connor 
2013 and Hussainy 2006, Borgsteede 2010). Where pharmacists have been trained to provide 
community palliative care services in Scotland, healthcare professionals saw them as their ‘first 
port of call’ for information about palliative medicines (Akram 2017). 
Although this is a small study the findings indicate that patients who are not receiving specialist 
palliative care seem less able to gain optimal use from their pain medicines and have no timely 
access to advice in times of worsening symptoms or crisis. This is supported by the Voices 
survey where only 18% of patients in community settings were likely to describe their pain as 
being completely controlled compared with 38% in hospital and 68% in hospice environments 
(VOICES 2014). Referral to palliative care is known to happen relatively late in the journey of a 
terminal cancer patient and one third of patients who die from cancer never receive specialist 
palliative care services (Ziegler, 2017). The idea of resilience of the patient to cope with 
problems has been found in other disease areas, not just palliative care (Fylan-Gwynn 2017). Of 
course, not all patients want to be referred to specialist palliative care or indeed, have the 
opportunity to be.  Therefore, a need exists for medicines support either before that referral 
occurs or for patients who stay under the care of their GP.  
Most patients found the idea of a community pharmacy medicines consultation acceptable 
whether face-to-face or by telephone. Patients felt that this would be of most value early on in 
the cancer pain journey and before the involvement of specialist services. Patients were 
generally uncomfortable with the idea of medicines consultations being carried out via Skype as 
there was a lack of access to equipment or unfamiliarity with technology. Patients were more 
positive about medicines consultations being conducted by phone and found the idea of this 
less burdensome in-terms of travel and time than a face-to-face consultation. Telephone-based 
consultations are now carried out on a routine basis with palliative care patients in another area 
of West Yorkshire (Middleton-Green 2016). There was a gap between the theoretical 
acceptability and the likelihood of actually using a medicines consultation service in the future. 
Patients’ need to experiment with their medication to try and achieve pain relief at the lowest 
possible dose was evident and this could be helped by educational interventions to either 
optimise the medicines they have already been prescribed, allay any fears or stigma 
surrounding the use of strong painkillers or to refer to prescribers for a dose change. This is 
backed up by previous research which found an improvement in pain scores for patients with 
cancer pain who received educational interventions (Bennett2009a). 
Strengths and limitations 
We encountered challenges with recruitment mainly due to potential participants being too 
unwell to participate and therefore views of patients with very advanced disease are not 
included.  
The study was conducted across a single UK city with a diverse socioeconomic population 
however we recognise the findings may not be transferable to other parts of the UK. 
Whilst the average age of participants was 64 years old and the majority were male there is 
evidence that older patients do not experience cancer pain differently although there is 
evidence to suggest that there are gender differences in healthcare utilisation (Bennett, Closs & 
Chatwin 2009, Wang 2013). 
The interviewer was a research pharmacist and their professional background was shared with 
the participants and potentially influencing the views expressed with a degree of participant 
eagerness to please and say the ‘right thing’ and paint community pharmacy in a positive light 
(Jack 2008). Conversely the background of the researcher aided understanding of issues 
throughout the interviews and therefore they acted as an ‘embedded researcher’ (Vindola-
Padros 2016). Reflexivity was practiced by the researcher throughout. 
At the beginning of the interview process, researchers were unaware of all important issues for 
the patients with regards access to equipment. This unfortunately, led to a small amount of 
missing data for computer ownership. We feel that as this was the case with such a small 
number of participants it does not devalue our findings. 
Any qualitative study relies on the interpretation of the data and this may affect the reliability of 
the results. In the current study this was mitigated by the involvement of other research team 
members in discussions about coding and during the write up of results. 
Implications of the study 
Our findings have implications for practice, policy and research. The most effective use of a 
community pharmacy medicines consultation appears to be for patients who are not receiving 
specialist palliative care and the pharmacists need to be appropriately trained in both theory 
and consultation skills to provide such a service. The development of referral pathways to 
identify these patients is a necessary next step and a pathway from community pharmacy to 
palliative care could be usefully explored. Based on the findings of the study reported here we 
have delivered NMS style consultations by telephone to patients with pain from advanced 
cancer and the results could inform future policy discussions. It is vital that any new service is 
designed with the needs of the patients in mind and is accessible for all who need it. Our 
findings show a need for medicines support for some patients with pain from advanced cancer 
and that they are receptive to a telephone-based consultation with a healthcare professional. 
 
Conclusion 
Patients experiencing pain from advanced cancer have complex and often changing medicines 
regimens which pose challenges in terms of management and optimisation. This study has 
shown that patients have unmet needs and indicate that targeted community pharmacist input 
from highly trained pharmacists as a potential information source for patients is worthy of 
further research. There is a need for medicines support for patients who have not yet been, or 
may not be referred to specialist palliative care.  Patients receiving care from specialist palliative 
care nurses valued their expertise and saw them as the first port of call for advice about pain 
medicines. Patients were receptive to the idea of a medicines consultation with a community 
pharmacist and were positive about this being carried out in a face-to-face setting or by 
telephone. Widening access to telephone medicines consultations could contribute to 
improving access to pain medicines support in advanced cancer. 
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